Gabapentin Solution
Product Images NDC 72162-1318

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72162-1318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Equation (Figure 01)

Equation (Figure 01)
An illustration showing a formula to calculate creatinine clearance (CLCr). The formula includes patient age in years, weight in kilograms, serum creatinine in mg/dL, and a multiplication factor of 0.85 for female patients.*
FDA Label Image

Chemical Structure (Figure 02)

Chemical Structure (Figure 02)
Chemical structure diagram of gabapentin, showing a cyclohexane ring attached to amine and carboxyl functional groups.*
FDA Label Image

Figure 1 (Figure 03)

Figure 1 (Figure 03)
Line graph comparing mean pain scores over an 8-week period between placebo and Gabapentin at 3600 mg/day. The X-axis represents time in weeks, starting from baseline to 8 weeks, divided into a 4-week dose titration period and a 4-week fixed dose period. The Y-axis shows mean pain scores ranging from 0 to 10. Gabapentin shows a declining pain score trend, while placebo remains relatively stable.*
FDA Label Image

Figure 2 (Figure 04)

Figure 2 (Figure 04)
A line graph showing mean pain scores over seven weeks during a clinical study with a 3-week dose titration period followed by a 4-week fixed dose period. It compares placebo with gabapentin at 1800 mg/day and 2400 mg/day, illustrating lower mean pain scores for both gabapentin doses compared to placebo over time.*
FDA Label Image

Figure 3 (Figure 05)

Figure 3 (Figure 05)
A bar chart comparing Study 1 and Study 2 results with percent values on the vertical axis up to 100%. Study 1 shows 12% for PBO and 29% for GBP 3600. Study 2 shows 14% for PBO, 32% for GBP 1800, and 34% for GBP 2400. Statistical significance is indicated with ** (p < 0.01) and *** (p < 0.001).*
FDA Label Image

Figure 4 (Figure 06)

Figure 4 (Figure 06)
A scatter plot chart showing percentage difference on the vertical axis and daily dose in milligrams on the horizontal axis. The chart compares data points from three studies labeled as Study a, Study b, and Study c, with daily doses ranging from 600 to 1800 mg and percentage differences from 2% to 22%.*
FDA Label Image

Logo (Figure 07)

Logo (Figure 07)
FDA Label Image

Label (Lbl721621318)

Label (Lbl721621318)
Gabapentin Oral Solution 250 mg/5 mL label showing a 470 mL container size. The label indicates the product is relabeled by Bryant Ranch Prepack, Inc. and manufactured by Acella Pharmaceuticals, LLC. It includes storage instructions, warnings, and dosing information with the NDC 72162-1318-4 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.